Your browser doesn't support javascript.
loading
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
Chatterjee, Bithi; Deng, Yun; Holler, Angelika; Nunez, Nicolas; Azzi, Tarik; Vanoaica, Liliana Danusia; Müller, Anne; Zdimerova, Hana; Antsiferova, Olga; Zbinden, Andrea; Capaul, Riccarda; Dreyer, Johannes H; Nadal, David; Becher, Burkhard; Robinson, Mark D; Stauss, Hans; Münz, Christian.
Afiliación
  • Chatterjee B; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Deng Y; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Holler A; Institute of Immunity and Transplantation, Royal Free Campus, University College London, United Kingdom.
  • Nunez N; Inflammation Research, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Azzi T; Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Vanoaica LD; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Müller A; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Zdimerova H; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Antsiferova O; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Zbinden A; Institute of Medical Virology, University of Zurich, Switzerland.
  • Capaul R; Institute of Medical Virology, University of Zurich, Switzerland.
  • Dreyer JH; Institute for Pathology, Unfallkrankenhaus Berlin, Berlin, Germany.
  • Nadal D; Inflammation Research, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Becher B; Inflammation Research, Institute of Experimental Immunology, University of Zurich, Switzerland.
  • Robinson MD; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
  • Stauss H; SIB Swiss Institute of Bioinformatics, Zurich, Switzerland.
  • Münz C; Institute of Immunity and Transplantation, Royal Free Campus, University College London, United Kingdom.
PLoS Pathog ; 15(5): e1007748, 2019 05.
Article en En | MEDLINE | ID: mdl-31145756
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Herpesvirus Humano 4 / Linfocitos T CD8-positivos / Carga Viral / Infecciones por Virus de Epstein-Barr / Receptor de Muerte Celular Programada 1 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Herpesvirus Humano 4 / Linfocitos T CD8-positivos / Carga Viral / Infecciones por Virus de Epstein-Barr / Receptor de Muerte Celular Programada 1 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2019 Tipo del documento: Article País de afiliación: Suiza